Liquidia Corporation

Liquidia makes medicines to treat rare lung diseases where blood pressure in the lungs becomes dangerously high. Their main product, YUTREPIA, is an inhaled powder form of a drug called treprostinil that patients breathe in to treat pulmonary arterial hypertension and related conditions. They also sell Remodulin, an injectable version of the same drug that patients receive through continuous infusion. The company has developed a manufacturing technology called PRINT that lets them create drug particles with precise size and shape, which they use in their own products and license to other pharm...